ABRAXIS PHARMACEUTICAL PRODUCTS Trademark

Trademark Overview


On Saturday, April 8, 2006, a trademark application was filed for ABRAXIS PHARMACEUTICAL PRODUCTS with the United States Patent and Trademark Office. The USPTO has given the ABRAXIS PHARMACEUTICAL PRODUCTS trademark a serial number of 78857203. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, May 11, 2018. This trademark is owned by American Pharmaceutical Partners, Inc.. The ABRAXIS PHARMACEUTICAL PRODUCTS trademark is filed in the Pharmaceutical Products, Advertising and Business and Retail Services categories with the following description:

Pharmaceuticals, namely, alkalizing agents, analgesics and anesthetics, antacids, anticholinergics, antihistamines, anti-infectives, anti-inflammatory agents, anticonvulsants, antidotes, antiemetics, antipsychotics, anxiolytics, blood modifiers, bronchodialators, cardiovasculars, diuretics, hormones, diluents, electrolytes, trace element preparations in the nature of mineral supplements for human consumption, vitamins, micronutrients, namely, nutritional supplements, oncolytics, immunosuppressive agents, transplantation agents, imaging agents, vascular targeting agents, and sensitizing agents for chemotherapy-resistant tumors; pharmaceuticals for treatment of cancer; pharmaceuticals to treat vascular diseases; drug delivery systems composed of nanoparticles sold as an integral component of drugs; injectable drugs and therapeutic solutions for the treatment of cancer and vascular diseases in the form of prefilled IV bags as a unit, sold separately or with devices for intravenous adminis...

distributorship and retail ordering services featuring pharmaceuticals, namely, alkalizing agents, analgesics and anesthetics, antacids, anticholinergics, antihistamines, anti-infectives, anti-inflammatory agents, anticonvulsants, antidotes, antiemetics, antipsychotics, anxiolytics, blood modifiers, bronchodialators, cardiovasculars, diuretics, hormones, diluents, electrolytes, trace elements, vitamins, micronutrients, oncolytics, immunosuppressive agents, transplantation agents, imaging agents, vascular targeting agents, and sensitizing agents for chemotherapy-resistant tumors; distributorship and retail ordering services featuring pharmaceuticals for the treatment of cancer, pharmaceuticals to treat vascular diseases, drug delivery systems composed of nanoparticles sold as an integral component of drugs; distribution and retail ordering services featuring IV bags for presentation with injectable drugs or therapeutic solutions and devices for intravenous administration of pharmaceutic...
abraxis pharmaceutical products

General Information


Serial Number78857203
Word MarkABRAXIS PHARMACEUTICAL PRODUCTS
Filing DateSaturday, April 8, 2006
Status710 - CANCELLED - SECTION 8
Status DateFriday, May 11, 2018
Registration Number3309636
Registration DateTuesday, October 9, 2007
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 19, 2006

Trademark Statements


Disclaimer with Predetermined Text"PHARMACEUTICAL PRODUCTS"
Goods and ServicesPharmaceuticals, namely, alkalizing agents, analgesics and anesthetics, antacids, anticholinergics, antihistamines, anti-infectives, anti-inflammatory agents, anticonvulsants, antidotes, antiemetics, antipsychotics, anxiolytics, blood modifiers, bronchodialators, cardiovasculars, diuretics, hormones, diluents, electrolytes, trace element preparations in the nature of mineral supplements for human consumption, vitamins, micronutrients, namely, nutritional supplements, oncolytics, immunosuppressive agents, transplantation agents, imaging agents, vascular targeting agents, and sensitizing agents for chemotherapy-resistant tumors; pharmaceuticals for treatment of cancer; pharmaceuticals to treat vascular diseases; drug delivery systems composed of nanoparticles sold as an integral component of drugs; injectable drugs and therapeutic solutions for the treatment of cancer and vascular diseases in the form of prefilled IV bags as a unit, sold separately or with devices for intravenous administration, namely, transfer pins, vials, needles, adaptors and tamper resistant seals sold as a kit
Goods and Servicesdistributorship and retail ordering services featuring pharmaceuticals, namely, alkalizing agents, analgesics and anesthetics, antacids, anticholinergics, antihistamines, anti-infectives, anti-inflammatory agents, anticonvulsants, antidotes, antiemetics, antipsychotics, anxiolytics, blood modifiers, bronchodialators, cardiovasculars, diuretics, hormones, diluents, electrolytes, trace elements, vitamins, micronutrients, oncolytics, immunosuppressive agents, transplantation agents, imaging agents, vascular targeting agents, and sensitizing agents for chemotherapy-resistant tumors; distributorship and retail ordering services featuring pharmaceuticals for the treatment of cancer, pharmaceuticals to treat vascular diseases, drug delivery systems composed of nanoparticles sold as an integral component of drugs; distribution and retail ordering services featuring IV bags for presentation with injectable drugs or therapeutic solutions and devices for intravenous administration of pharmaceuticals, namely, transfer pins, vials, needles, pumping chamber sets, lubricants, adaptors and tamper resistant seals

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, May 11, 2018
Primary Code005
First Use Anywhere DateMonday, May 1, 2006
First Use In Commerce DateMonday, May 1, 2006

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, May 11, 2018
Primary Code035
First Use Anywhere DateMonday, May 1, 2006
First Use In Commerce DateMonday, May 1, 2006

Trademark Owner History


Party NameABRAXIS BIOSCIENCE, LLC
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressSummit, NJ 07901

Party NameAbraxis Bioscience, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLos Angeles, CA 90025

Party NameAbraxis Bioscience, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLos Angeles, CA 90025

Party NameAbraxis Bioscience, Inc.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressLos Angeles, CA 90049

Party NameAmerican Pharmaceutical Partners, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSchaumburg, IL 601735837

Trademark Events


Event DateEvent Description
Friday, May 11, 2018CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Sunday, October 9, 2016COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Monday, January 25, 2016APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, January 25, 2016TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, July 27, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, October 31, 2012NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Wednesday, October 31, 2012REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, October 31, 2012CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, October 10, 2012TEAS SECTION 8 & 15 RECEIVED
Friday, October 15, 2010ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 15, 2010TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, December 5, 2007AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, October 9, 2007REGISTERED-PRINCIPAL REGISTER
Thursday, September 6, 2007LAW OFFICE REGISTRATION REVIEW COMPLETED
Thursday, September 6, 2007ASSIGNED TO LIE
Sunday, July 29, 2007ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, July 2, 2007STATEMENT OF USE PROCESSING COMPLETE
Monday, July 2, 2007EXTENSION 1 GRANTED
Friday, June 8, 2007EXTENSION 1 FILED
Tuesday, April 3, 2007USE AMENDMENT FILED
Friday, June 8, 2007TEAS EXTENSION RECEIVED
Monday, May 7, 2007APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, May 7, 2007TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, April 3, 2007TEAS STATEMENT OF USE RECEIVED
Tuesday, December 12, 2006NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 19, 2006PUBLISHED FOR OPPOSITION
Wednesday, August 30, 2006NOTICE OF PUBLICATION
Thursday, July 27, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, July 27, 2006ASSIGNED TO LIE
Thursday, July 6, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 6, 2006EXAMINER'S AMENDMENT ENTERED
Thursday, July 6, 2006EXAMINERS AMENDMENT E-MAILED
Thursday, July 6, 2006EXAMINERS AMENDMENT -WRITTEN
Saturday, July 1, 2006AMENDMENT FROM APPLICANT ENTERED
Tuesday, June 20, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 20, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 20, 2006COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED
Tuesday, June 20, 2006ASSIGNED TO LIE
Monday, June 19, 2006EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Monday, June 19, 2006EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Tuesday, June 13, 2006ASSIGNED TO EXAMINER
Wednesday, June 7, 2006ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, April 18, 2006NEW APPLICATION ENTERED IN TRAM